Menu Back toSpotlight Symposia: Pragmatic Innovation in Clinical Trials: Broader Access, Better Evidence, and Faster Approvals

DIA 2021 Global Annual Meeting


Spotlight Symposia: Pragmatic Innovation in Clinical Trials: Broader Access, Better Evidence, and Faster Approvals

Session Chair(s)

  ERT

ERT

  • United States
As the clinical trial landscape continues to evolve in the wake of COVID-19, now is the time to accelerate the transformation of patients' lives by unlocking better evidence through pragmatic innovation. The pandemic uncovered challenges, such as patient access, that lead to delays in start-up and delivery. Hear from leading experts as they discuss future trends and how smart drug developers can leverage technology to bring new innovations to market faster than ever before.

Speaker(s)

Madeline  Geday

Madeline Geday

  • Senior Director, Head of Patient Engagement
  • ERT, United States
Dan  Gebow, PhD

Dan Gebow, PhD

  • Chief Innovation Officer
  • Bioclinica, United States
Elisa  Cascade, MBA

Elisa Cascade, MBA

  • Executive Vice President, eCOA
  • ERT, United States
AJ  Mills

AJ Mills

  • Vice President, eCOA Solutions
  • ERT, United States
Otis  Johnson

Otis Johnson

  • VP & Product Line Executive and Chief Diversity Officer
  • ERT, United States